Cardio Diagnostics Holdings Stock Performance

CDIOW Stock  USD 0.04  0.0001  0.24%   
Cardio Diagnostics holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.76, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cardio Diagnostics will likely underperform. Use Cardio Diagnostics value at risk, as well as the relationship between the kurtosis and market facilitation index , to analyze future returns on Cardio Diagnostics.

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cardio Diagnostics Holdings are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Cardio Diagnostics showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Cardio Diagnostics Holdings, Inc. Short Interest Down 7.9 percent in July - Defense World
08/19/2024
2
Acquisition by Philibert Robert of 16000 shares of Cardio Diagnostics at 0.6 subject to Rule 16b-3
09/06/2024
3
Potential Catalyst Right Around The Corner CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics Heart Disease Tests - Yahoo Finance
09/17/2024
4
Cardio Diagnostics Holdings, Inc. Sees Large Increase in Short Interest
10/30/2024
5
Disposition of tradable shares by Levy Oded of Cardio Diagnostics subject to Rule 16b-3
11/01/2024
6
Cardio Diagnostics shareholders approve key proposals - Investing.com
11/18/2024
Begin Period Cash Flow4.1 M
  

Cardio Diagnostics Relative Risk vs. Return Landscape

If you would invest  3.35  in Cardio Diagnostics Holdings on August 25, 2024 and sell it today you would earn a total of  0.75  from holding Cardio Diagnostics Holdings or generate 22.39% return on investment over 90 days. Cardio Diagnostics Holdings is currently producing 17.9414% returns and takes up 137.924% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Cardio, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Cardio Diagnostics is expected to generate 179.47 times more return on investment than the market. However, the company is 179.47 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of risk.

Cardio Diagnostics Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cardio Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cardio Diagnostics Holdings, and traders can use it to determine the average amount a Cardio Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1301

Best PortfolioBest EquityCDIOW
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 137.92
  actual daily
96
96% of assets are less volatile

Expected Return

 5.01
  actual daily
96
96% of assets have lower returns

Risk-Adjusted Return

 0.13
  actual daily
10
90% of assets perform better
Based on monthly moving average Cardio Diagnostics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cardio Diagnostics by adding it to a well-diversified portfolio.

Cardio Diagnostics Fundamentals Growth

Cardio Stock prices reflect investors' perceptions of the future prospects and financial health of Cardio Diagnostics, and Cardio Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cardio Stock performance.

About Cardio Diagnostics Performance

Evaluating Cardio Diagnostics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Cardio Diagnostics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cardio Diagnostics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.13)(2.24)
Return On Capital Employed(2.00)(2.10)
Return On Assets(1.88)(1.97)
Return On Equity(2.83)(2.97)

Things to note about Cardio Diagnostics performance evaluation

Checking the ongoing alerts about Cardio Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cardio Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cardio Diagnostics is way too risky over 90 days horizon
Cardio Diagnostics has some characteristics of a very speculative penny stock
Cardio Diagnostics appears to be risky and price may revert if volatility continues
Cardio Diagnostics has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 17.07 K. Net Loss for the year was (8.38 M) with profit before overhead, payroll, taxes, and interest of 0.
Cardio Diagnostics generates negative cash flow from operations
Cardio Diagnostics has a poor financial position based on the latest SEC disclosures
Latest headline from news.google.com: Cardio Diagnostics shareholders approve key proposals - Investing.com
Evaluating Cardio Diagnostics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cardio Diagnostics' stock performance include:
  • Analyzing Cardio Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cardio Diagnostics' stock is overvalued or undervalued compared to its peers.
  • Examining Cardio Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cardio Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cardio Diagnostics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Cardio Diagnostics' stock. These opinions can provide insight into Cardio Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cardio Diagnostics' stock performance is not an exact science, and many factors can impact Cardio Diagnostics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Cardio Stock Analysis

When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.